OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment
2023
Source PublicationTHERANOSTICS
ISSN1838-7640
Volume13Issue:12
Status已发表
DOI10.7150/thno.83495
AbstractRationale:The resistance of pancreatic ductal adenocarcinoma (PDAC) to immunotherapies is caused by the immunosuppressive tumor microenvironment (TME) and dense extracellular matrix. Currently, the efficacy of an isolated strategy targeting stromal desmoplasia or immune cells has been met with limited success in the treatment of pancreatic cancer. Oncolytic virus (OV) therapy can remodel the TME and damage tumor cells either by directly killing them or by enhancing the anti-tumor immune response, which holds promise for the treatment of PDAC. This study aimed to investigate the therapeutic effect of OX40L-armed OV on PDAC and to elucidate the underlying mechanisms. Methods:Murine OX40L was inserted into herpes simplex virus-1 (HSV-1) to construct OV-mOX40L. Its expression and function were assessed using reporter cells, cytopathic effect, and immunogenic cell death assays. The efficacy of OV-mOX40L was then evaluated in a KPC syngeneic mouse model. Tumor-infiltrating immune and stromal cells were analyzed using flow cytometry and single-cell RNA sequencing to gain insight into the mechanisms of oncolytic virotherapy. Results:OV-mOX40L treatment delayed tumor growth in KPC tumor-bearing C57BL/6 mice. It also boosted the tumor-infiltrating CD4+ T cell response, mitigated cytotoxic T lymphocyte (CTL) exhaustion, and reduced the number of regulatory T cells. The treatment of OV-mOX40L reprogrammed macrophages and neutrophils to a more pro-inflammatory anti-tumor state. In addition, the number of myofibroblastic cancer-associated fibroblasts (CAF) was reduced after treatment. Based on single-cell sequencing analysis, OV-mOX40L, in combination with anti-IL6 and anti-PD-1, significantly extended the lifespan of PDAC mice. Conclusion:OV-mOX40L converted the immunosuppressive tumor immune microenvironment to a more activated state, remodeled the stromal matrix, and enhanced T cell response. OV-mOX40L significantly prolonged the survival of PDAC mice, either as a monotherapy or in combination with synergistic antibodies. Thus, this study provides a multimodal therapeutic strategy for pancreatic cancer treatment.
Keywordoncolytic virus pancreatic cancer OX40L tumor immune microenvironment T cell
URL查看原文
Indexed BySCI
Language英语
Funding ProjectNational Natural Science Foundation of China["32271529","82273843"] ; China Postdoctoral Science Foundation[ZB19100123] ; Fundamental Research Funds for the Central Universities, Nankai University[XB202010] ; Key Research Fund of Tianjin Project and Team[20YFZCSY00450] ; Key Research and Development Program of Tianjin[82261138553] ; null[2020M670625]
WOS Research AreaResearch & Experimental Medicine
WOS SubjectMedicine, Research & Experimental
WOS IDWOS:001042558200010
PublisherIVYSPRING INT PUBL
Citation statistics
Document Type期刊论文
Identifierhttps://kms.shanghaitech.edu.cn/handle/2MSLDSTB/323572
Collection免疫化学研究所
免疫化学研究所_公共科研平台_高通量筛选平台
免疫化学研究所_公共科研平台_生物医学大数据平台
免疫化学研究所_特聘教授组_张宏恺组
Corresponding AuthorZhang, Hongkai; Wang, Wei; Wang, Hui; Wang, Yuan
Affiliation
1.Nankai Univ, State Key Lab Med Chem Biol, Tianjin, Peoples R China
2.Nankai Univ, Coll life Sci, Tianjin, Peoples R China
3.CNBG Nankai Univ Joint Res & Dev Ctr, Tianjin, Peoples R China
4.ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai, Peoples R China
5.Tianjin First Cent Hosp, Dept Hematol, Tianjin 300192, Peoples R China
Corresponding Author AffilicationShanghai Institute for Advanced Immunochemical Studies
Recommended Citation
GB/T 7714
Liu, Shiyu,Li, Fan,Ma, Qiongqiong,et al. OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment[J]. THERANOSTICS,2023,13(12).
APA Liu, Shiyu.,Li, Fan.,Ma, Qiongqiong.,Du, Mingjuan.,Wang, Haoran.,...&Wang, Yuan.(2023).OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment.THERANOSTICS,13(12).
MLA Liu, Shiyu,et al."OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment".THERANOSTICS 13.12(2023).
Files in This Item: Download All
File Name/Size DocType Version Access License
Related Services
Usage statistics
Scholar Google
Similar articles in Scholar Google
[Liu, Shiyu]'s Articles
[Li, Fan]'s Articles
[Ma, Qiongqiong]'s Articles
Baidu academic
Similar articles in Baidu academic
[Liu, Shiyu]'s Articles
[Li, Fan]'s Articles
[Ma, Qiongqiong]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Liu, Shiyu]'s Articles
[Li, Fan]'s Articles
[Ma, Qiongqiong]'s Articles
Terms of Use
No data!
Social Bookmark/Share
File name: 10.7150@thno.83495.pdf
Format: Adobe PDF
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.